HeidiJoyGrayMD
Obstetrics & Gynecology • Seattle, WAGynecologic Oncology
Professor and Chief, Division of Gyn Oncology, Obstetrics & Gynecology, University of Washington School of Medicine
Overview of Dr. Gray
Dr. Heidi Gray is an obstetrician/gynecologist in Seattle, WA and is affiliated with multiple hospitals in the area, including UW Medicine/University of Washington Medical Center and Fred Hutch Cancer Center. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 20 years. Dr. Gray accepts several types of health insurance, listed below. She is one of 174 doctors at UW Medicine/University of Washington Medical Center and one of 17 doctors at Fred Hutch Cancer Center who specialize in Obstetrics & Gynecology. She has more than 70 publications and over 500 citings.
Office
1959 Ne Pacific St
Seattle, WA 98195Fax+1 206-598-3590
Education & Training
University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 2001 - 2004
University of WashingtonResidency, Obstetrics and Gynecology, 1997 - 2001
David Geffen School of Medicine at UCLAClass of 1997
Certifications & Licensure
WA State Medical License 1999 - 2025
PA State Medical License 2001 - 2004- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Ovarian Cancer Vaccine for Patients in Remission Start of enrollment: 2010 Jul 01
- Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms Start of enrollment: 2012 Sep 12
Publications & Presentations
PubMed
- NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham
Journal of the National Comprehensive Cancer Network. 2024-10-01 - 4 citationsNRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.Tracy T Batchelor, Minhee Won, Arnab Chakravarti, Costas G Hadjipanayis, Wenyin Shi
Neuro-Oncology Advances. 2023-10-11 - Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.Aaron M Praiss, Austin Miller, Judith Smith, Stuart M Lichtman, Michael Bookman
Gynecologic Oncology. 2023-07-01
Other
- Adjuvant treatment of intermediate-risk endometrial cancerGray HJ, Koh W
http://www.uptodate.com/contents/adjuvant-treatment-of-intermediate-risk-endometrial-cancer
UpToDate, Wolters Kluwer Health - 2012-08-14
Press Mentions
PARIS® Test Identified Effective Therapy for Patient with Terminal Ovarian CancerSeptember 13th, 2021- SEngine Precision Medicine Presents Data at 2021 AACR Annual Meeting Demonstrating Clinical Utility and Predictive Value of PARIS® Test in Ovarian CancerApril 13th, 2021
SGO 2019: Despite Missed Endpoint, JAVELIN Trial PD-L1 Subgroup Analysis RedeemsMarch 19th, 2019
Professional Memberships
- Fellow
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Choice
First Health PPO
Great West PPO
Health Alliance PPO
Health Net Oregon PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
ODS Network
Premera BCBS Heritage & Heritage Plus 1
Providence Health System Personal Option
Regence Washington - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Wellmark Alliance Select - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
